Novogene Europe has expanded its Cambridge Omics Centre with the [...]

ProMIS Neurosciences has reported the first human evidence that its [...]

Erasca has reported updated preliminary Phase 1 data for its [...]

Tenpoint Therapeutics has submitted a Marketing Authorization Application (MAA) to [...]

New Phase 1 data show Vandria’s VNA-318 reaches the human [...]

Researchers have developed a new way to precisely control organic [...]

En Carta Diagnostics has raised €5 million to support regulatory [...]

Messenger RNA (mRNA) technology could offer a new approach to [...]

A Phase 1/1b clinical trial has begun in Australia to [...]

ATSN-401, Atsena Therapeutics’ investigational gene therapy for Stargardt disease, has [...]